Secondary analysis of TEMPO-2 (865 of 884 patients with minor ischaemic stroke analysed): any intracranial haemorrhage (11.8%) was not associated with lower odds of returning to baseline function (aOR 0.93) but was with higher 90-day mortality (9.8% v 1.8%; aHR 3.71).
Secondary analysisn = 884
Massicotte et al. Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial